C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy

C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy

Despite the implementation of consolidative immune checkpoint inhibition after definitive chemoradiotherapy (CRT), the prognosis for locally advanced non-small-cell lung cancer (NSCLC) remains poor. We assessed the impact of the C-reactive protein (CRP) to albumin ratio (CAR) as an inflammation-base...

Full description

Bibliographic Details
Main Authors: Alina Frey, Daniel Martin, Louisa D’Cruz, Emmanouil Fokas, Claus Rödel, Maximilian Fleischmann
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Biomedicines
Subjects:
NSCLC
chemoradiotherapy
CRT
CAR
C-reactive protein
albumin
Online Access:https://www.mdpi.com/2227-9059/10/3/598

Internet

https://www.mdpi.com/2227-9059/10/3/598

Similar Items